Results 301 to 310 of about 843,078 (353)
Some of the next articles are maybe not open access.
Therapeutic potentials of curcumin in the treatment of non‐small‐cell lung carcinoma
Phytotherapy Research, 2020Non‐small‐cell lung carcinoma (NSCLC) is one of the most lethal malignancies that include more than 80% of lung cancer cases worldwide. During the past decades, plants and plant‐derived products have attracted great interest in the treatment of various ...
Mahsa Salehi +11 more
semanticscholar +1 more source
Genes and Pathology of Non-Small Cell Lung Carcinoma
Seminars in Oncology, 2014While histopathology has traditionally been the cornerstone of treatment decisions in the management of lung cancer patients, the complexity and heterogeneity of histological classification has had a limited impact in the routine practice of oncology. This has changed dramatically in the last few years, owing to discoveries of genomic aberrations and ...
Shingo, Sakashita +2 more
openaire +2 more sources
Drugs, 1995
Non-small-cell lung cancer (NSCLC) is one of the most common malignancies in developed countries and accounts for millions of deaths worldwide. The incidence of NSCLC correlates with smoking tobacco and is likely to increase in those countries with increasing per capita consumption of tobacco.
K T, Bastin, R, Curley
openaire +2 more sources
Non-small-cell lung cancer (NSCLC) is one of the most common malignancies in developed countries and accounts for millions of deaths worldwide. The incidence of NSCLC correlates with smoking tobacco and is likely to increase in those countries with increasing per capita consumption of tobacco.
K T, Bastin, R, Curley
openaire +2 more sources
Tumor Stage in Non-Small Cell Carcinoma of the Lung
Chest, 1991This article is the second in a planned series from the Section on Cancer of the ACCP. The first article (Little AG, Stitik FP: Clinical staging of patients with non-small cell lung cancer. Chest 97:1431-38, 1990) focused on clinical approaches to staging and emphasized the role of: (1) radionuclide scanning; (2) computed tomography; (3) magnetic ...
C F, Mountain +2 more
openaire +2 more sources
Integrin expression in non-small cell carcinoma of the lung
Cancer and Metastasis Reviews, 1995Alteration of integrin expression in a number of different malignant diseases has been recognized, with a trend of downregulation of collagen-laminin binding integrin expression in epithelial tumor types noted. This study evaluated the expression of a panel of integrin subunits that included subunits that form receptors that bind to collagen and ...
W R, Smythe +4 more
openaire +2 more sources
Non-Small-Cell Carcinoma of the Lung
1991It is estimated that in the United States during 1989, 155000 cases of carcinoma of the lung will occur and that close to 142000 of these patients will die within 1 year from their disease (Silver-Berg and Lubera 1989). At present in the United States, the incidence and death rate from this disease for females has surpassed that for breast cancer in ...
Hassan Aziz +4 more
openaire +1 more source
Curative radiotherapy in non-small cell carcinoma of the lung
International Journal of Radiation Oncology*Biology*Physics, 1990Recent reports suggest radiotherapy administered to the 5000-6000 cGy level can result in significant long-term survival in non-small cell carcinoma of the lung. This is particularly true for many cases that are technically operable but for medical or other reasons thoracotomy cannot be performed.
B M, Talton, W C, Constable, C R, Kersh
openaire +2 more sources
Molecular Diagnostics in Non-Small Cell Lung Carcinoma
Seminars in Respiratory and Critical Care Medicine, 2020AbstractCurrent clinical practice guidelines recognize EGFR, BRAF, ALK, and ROS1 as essential molecular biomarkers, and a host of other genetic alterations as emerging biomarkers for non-small cell lung carcinoma patients. The available approaches to detecting relevant alterations in these genes are diverse and often complementary.
openaire +2 more sources
Elastase levels in small and non - small cell lung carcinoma
Biochemical Society Transactions, 1993Elastase (E.C.3.4.21.37) constitutes the most important component in the proteolytic enzyme spectrum of neutrophilic granulocytes [ I ] . Elastase is the only enzyme which can hydrolyze insoluble elastin 121. In addition, elastase can hydrolyze several other tissue components including connective tissue macromolecules, plasma proteinase inhibitors and ...
Güner, G +4 more
openaire +4 more sources
Chromogranin A gene expression in non‐small cell lung carcinomas
The Journal of Pathology, 1998Evidence for the existence of neuroendocrine (NE) differentiation in non-small cell lung carcinomas (NSCLCs) is at present based on histochemical, ultrastructural, and immunohistochemical data. The aim of this study was to investigate the extent of NE differentiation in NSCLCs as revealed by mRNA analysis.
ABBONA G. +5 more
openaire +3 more sources